These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 15176166)

  • 21. Infliximab treatment results in significant improvement in the quality of life of patients with severe psoriasis: a double-blind placebo-controlled trial.
    Feldman SR; Gordon KB; Bala M; Evans R; Li S; Dooley LT; Guzzo C; Patel K; Menter A; Gottlieb AB
    Br J Dermatol; 2005 May; 152(5):954-60. PubMed ID: 15888152
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Infliximab induction therapy for patients with severe plaque-type psoriasis: a randomized, double-blind, placebo-controlled trial.
    Gottlieb AB; Evans R; Li S; Dooley LT; Guzzo CA; Baker D; Bala M; Marano CW; Menter A
    J Am Acad Dermatol; 2004 Oct; 51(4):534-42. PubMed ID: 15389187
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Psoriasiform and pustular eruption induced by infliximab.
    Takahashi H; Hashimoto Y; Ishida-Yamamoto A; Ashida T; Kohgo Y; Iizuka H
    J Dermatol; 2007 Jul; 34(7):468-72. PubMed ID: 17584325
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Programmed cell death of keratinocytes in infliximab-treated plaque-type psoriasis.
    Krüger-Krasagakis S; Galanopoulos VK; Giannikaki L; Stefanidou M; Tosca AD
    Br J Dermatol; 2006 Mar; 154(3):460-6. PubMed ID: 16445776
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Personal experience with the use of infliximab].
    Carretero G
    Actas Dermosifiliogr; 2008 Jul; 99 Suppl 4():36-42. PubMed ID: 19080990
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Urticarial vasculitis due do infliximab.
    Goulão J; Cunha H; Anes I; Bártolo E; Furtado C; Serrano P; Brandão FM
    J Eur Acad Dermatol Venereol; 2008 Jul; 22(7):882-3. PubMed ID: 18462298
    [No Abstract]   [Full Text] [Related]  

  • 27. Infliximab monotherapy in psoriasis: a case of rapid clinical and histological response.
    Vincek V; Jacob SE; Nassiri M; Herbert LM; Nadji M; Kerdel FA
    Int J Dermatol; 2004 Apr; 43(4):303-8. PubMed ID: 15090021
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Infliximab treatment of psoriasis in supervised infusion centers: case management experience.
    Campos Muñoz L; de Unamuno Bustos B; Herranz Pinto P; El Ahmed HH; Ruiz-Villaverde R; Taberner Ferrer R
    Am J Clin Dermatol; 2014 Feb; 15 Suppl 1():S17-24. PubMed ID: 24777572
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of new-onset psoriasis in a patient receiving infliximab for treatment of rheumatoid arthritis.
    Chan CY; Browning JC; Larsen F; Hsu S
    Dermatol Online J; 2008 Sep; 14(9):12. PubMed ID: 19061594
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autoimmune hepatitis associated with infliximab in a patient with palmoplantar pustular psoriaisis.
    Fairhurst DA; Sheehan-Dare R
    Clin Exp Dermatol; 2009 Apr; 34(3):421-2. PubMed ID: 19309375
    [No Abstract]   [Full Text] [Related]  

  • 31. Serum sickness following treatment with rituximab.
    Todd DJ; Helfgott SM
    J Rheumatol; 2007 Feb; 34(2):430-3. PubMed ID: 17295433
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Infliximab in the treatment of psoriasis in patients previously treated with etanercept.
    Haitz KA; Kalb RE
    J Am Acad Dermatol; 2007 Jul; 57(1):120-5. PubMed ID: 17482715
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Psoriasiform eruption induced by infliximab.
    Verea MM; Del Pozo J; Yebra-Pimentel MT; Porta A; Fonseca E
    Ann Pharmacother; 2004 Jan; 38(1):54-7. PubMed ID: 14742794
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Repeated infliximab therapy after serum sickness-like reaction in Crohn's disease.
    Miheller P; Muzes G; Lakatos G; Mihály E; Tulassay Z
    J Emerg Med; 2007 Feb; 32(2):209-10; author reply 210. PubMed ID: 17307639
    [No Abstract]   [Full Text] [Related]  

  • 35. Cutaneous adverse reaction to infliximab: report of psoriasis developing in 3 patients.
    Severs GA; Lawlor TH; Purcell SM; Adler DJ; Thompson R
    Cutis; 2007 Sep; 80(3):231-7. PubMed ID: 17956013
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New-onset psoriatic palmoplantaris pustulosis following infliximab therapy: a class effect?
    Roux CH; Brocq O; Leccia N; Giacchero D; Breuil V; Albert C; Lacour J; Perrin C; Euller-Ziegler L
    J Rheumatol; 2007 Feb; 34(2):434-7. PubMed ID: 17295430
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of recalcitrant pustular psoriasis with infliximab: effective reduction of chemokine expression.
    Benoit S; Toksoy A; Bröcker EB; Gillitzer R; Goebeler M
    Br J Dermatol; 2004 May; 150(5):1009-12. PubMed ID: 15149518
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Successful treatment of hand and foot psoriasis with infliximab.
    Di Lernia V; Guareschi E
    Dermatol Online J; 2010 Jul; 16(7):8. PubMed ID: 20673536
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis: results from the infliximab multinational psoriatic arthritis controlled trial (IMPACT).
    Antoni CE; Kavanaugh A; Kirkham B; Tutuncu Z; Burmester GR; Schneider U; Furst DE; Molitor J; Keystone E; Gladman D; Manger B; Wassenberg S; Weier R; Wallace DJ; Weisman MH; Kalden JR; Smolen J
    Arthritis Rheum; 2005 Apr; 52(4):1227-36. PubMed ID: 15818699
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Our experience with infliximab in reclacitrant cases of psoriasis].
    Pereiro M; González-Vilas D; Sánchez-Aguilar D; Toribio J
    Actas Dermosifiliogr; 2008 Jul; 99 Suppl 4():43-7. PubMed ID: 19080991
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.